U.S. patent 8377674: Method for producing genetically-modified cells with rationally-designed meganucleases with altered sequence specificity. Granted to Smith et. al. on 2013-02-19 (filed None). Currently involved in at least 1 patent litigation: Precision Biosciences Inc. et. al. v. Cellectis S.A. et. al. (Delaware). See http://news.priorsmart.com for more info.
Original Title
Method for producing genetically-modified cells with rationally-designed meganucleases with altered sequence specificity (US patent 8377674)
U.S. patent 8377674: Method for producing genetically-modified cells with rationally-designed meganucleases with altered sequence specificity. Granted to Smith et. al. on 2013-02-19 (filed None). Currently involved in at least 1 patent litigation: Precision Biosciences Inc. et. al. v. Cellectis S.A. et. al. (Delaware). See http://news.priorsmart.com for more info.
U.S. patent 8377674: Method for producing genetically-modified cells with rationally-designed meganucleases with altered sequence specificity. Granted to Smith et. al. on 2013-02-19 (filed None). Currently involved in at least 1 patent litigation: Precision Biosciences Inc. et. al. v. Cellectis S.A. et. al. (Delaware). See http://news.priorsmart.com for more info.